A detailed history of Parkworth Wealth Management, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Parkworth Wealth Management, Inc. holds 16 shares of INCY stock, worth $1,375. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16
Previous 3 433.33%
Holding current value
$1,375
Previous $182,000 498.9%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$55.17 - $71.22 $717 - $925
13 Added 433.33%
16 $1.09 Million
Q4 2024

Feb 07, 2025

BUY
$65.08 - $83.38 $195 - $250
3 New
3 $207,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $19.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Parkworth Wealth Management, Inc. Portfolio

Follow Parkworth Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkworth Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Parkworth Wealth Management, Inc. with notifications on news.